Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

50 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 14, 2026Apr 14 8:02 PMSANDRA CALVIN
Proposed Sale
21,977$41.07$902.6K

View →

Apr 13, 2026Apr 14 12:11 AMChristopher Cline
Proposed Sale
65$28.85$1.9K

View →

Apr 6, 2026Apr 7 10:17 PMRoy D. BaynesDirector
Sale
10,000$33.00$330.0K37,500(D)

View →

Apr 6, 2026Apr 6 8:06 PMROY BAYNES
Proposed Sale
10,000$33.00$330.0K

View →

Apr 1, 2026Apr 2 9:55 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
60,000$30.93$1.9M432,886(D)

View →

Apr 1, 2026Apr 2 9:55 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$30.00$300.0K105,211(D)

View →

Apr 1, 2026Apr 1 8:13 PMDube Eric M
Proposed Sale
60,000$30.93$1.9M

View →

Apr 1, 2026Apr 1 8:06 PMELIZABETH REED
Proposed Sale
10,000$30.00$300.0K

View →

Mar 16, 2026Mar 18 8:05 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$28.09$280.9K105,211(D)

View →

Mar 16, 2026Mar 16 8:20 PMELIZABETH REED
Proposed Sale
10,000$28.09$280.9K

View →

Feb 20, 2026Feb 24 9:05 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
60,000$30.10$1.8M432,886(D)

View →

Feb 20, 2026Feb 20 9:49 PMDube Eric M
Proposed Sale
60,000$30.10$1.8M

View →

Feb 17, 2026Feb 19 9:10 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$27.83$278.3K105,211(D)

View →

Feb 17, 2026Feb 17 9:30 PMELIZABETH REED
Proposed Sale
10,000$27.83$278.3K

View →

Feb 4, 2026Feb 5 9:05 PMJula InrigCHIEF MEDICAL OFFICER
Sale
1,779$32.21$57.3K105,706(D)

View →

Feb 4, 2026Feb 5 9:05 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
1,745$32.19$56.2K111,226(D)

View →

Feb 4, 2026Feb 5 9:05 PMElizabeth E ReedChief Legal Officer and GC
Sale
2,994$32.18$96.4K105,211(D)

View →

Feb 4, 2026Feb 4 9:07 PMELIZABETH REED
Proposed Sale
2,994$32.18$96.4K

View →

Feb 4, 2026Feb 4 9:06 PMJULA INRIG
Proposed Sale
1,779$32.21$57.3K

View →

Feb 4, 2026Feb 4 9:01 PMCHRISTOPHER CLINE
Proposed Sale
1,745$32.19$56.2K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 12, 2026Jun 16 8:46 PMTimothy CoughlinDirector
Option Exercise
10,000$26.520(D)

View →

Jun 12, 2026Jun 16 8:42 PMRoy D. BaynesDirector
Option Exercise
4,500$21.380(D)

View →

May 19, 2026May 21 9:00 PMBrinkley Ruth WilliamsDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRon SquarerDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSandra PooleDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMJohn A OrwinDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMMeckler Jeffrey ADirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMLYONS GARY ADirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMTimothy CoughlinDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSuzanne Louise BruhnDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRoy D. BaynesDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 5, 2026May 7 12:00 AMRoy D. BaynesDirector
Option Exercise
4,500$18.270(D)

View →

May 4, 2026May 7 12:00 AMMeckler Jeffrey ADirector
Option Exercise
8,000$16.330(D)

View →

May 4, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Option Exercise
4,2504,250(D)

View →

May 4, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Option Exercise
24,250$17.964,250(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Option Exercise
24,250$22.404,250(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMPeter HeermaCHIEF COMMERCIAL OFFICER
Option Exercise
4,2504,250(D)

View →

Page 1 of 3

Next →